Akèy › BPCO › Florid › Orlando
Etid klinik pou BPCO nan Orlando, FL
15 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- Heuer M.D. Research- Site Number : 8400018, Orlando
- Florida Institute for Clinical Research- Site Number : 8400001, Orlando
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Ap rekriteFaz 2
- International Clinical Research, Altamonte Springs · 9 mi lwen
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Ap rekriteFaz 2
- Florida Institute For Clinical Research, LLC, Orlando
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- Omega Research Consultants - Orlando - Forest City- Site Number : 8400015, Orlando
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Ap rekrite
- Orlando Health, Orlando
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 2
- Research Site, Winter Park · 5 mi lwen
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Ap rekriteFaz 3
- Research Site, Winter Park · 5 mi lwen
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Ap rekriteFaz 3
- Research Site, Orlando
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 2/3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi lwen
- Clinical Research Specialists LLC, Kissimmee · 16 mi lwen
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 3
- Research Site, Orlando
- Research Site, Orlando
- Research Site, Orlando
- ak 1 plis
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Ap rekriteFaz 3
- GSK Investigational Site, Orlando
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Ap rekrite
- Orlando Health, Orlando
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Ap rekriteFaz 3
- GSK Investigational Site, Orlando
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Ap rekriteEtid obsèvasyon
- Charter Research, Winter Park · 5 mi lwen
- I.H.S Health, LLC, Kissimmee · 16 mi lwen
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Ap rekrite
- Alloy Clinical Research, Kissimmee · 16 mi lwen
Etid BPCO nan lòt vil
- Philadelphia, PA23 etid
- Miami, FL18 etid
- Birmingham, AL17 etid
- Boston, MA17 etid
- Houston, TX15 etid
- Baltimore, MD14 etid
- Chicago, IL14 etid
- Pittsburgh, PA12 etid
- Dallas, TX12 etid
- New York City, NY11 etid
- Ann Arbor, MI10 etid
- Detroit, MI9 etid
Lòt etid nan Orlando
- Kansè Poumon ki pa ti selil44 etid
- Obèsite31 etid
- Kansè Metastatik29 etid
- Sipwa27 etid
- Maladi Alzheimer25 etid
- Dyabèt Tip 224 etid
- Kansè (tout kalite)24 etid
- Kolit Ulseratif23 etid
- Kansè nan tete23 etid
- Kansè ovè22 etid
- Kansè poumon21 etid
- Kansè kolorektal19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.